UnitedHealth Group Inc (UNH) Stock Gains 1.82% This Week; Should You Buy?

Thursday, May 14, 2020 2:08 PM | InvestorsObserver Analysts

UnitedHealth Group Inc (UNH) stock has gained 22.92% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives UNH stock a score of 78 out of a possible 100.

That rank is primarily influenced by a short-term technical score of 90. UNH's rank also includes a long-term technical score of 88. The fundamental score for UNH is 56. In addition to the average rating from Wall Street analysts, UNH stock has a mean target price of 319.611. This means analysts expect the stock to gain 10.13% over the next 12 months.

Overall Score - 78
UNH has an Overall Score of 78. Find out what this means to you and get the rest of the rankings on UNH!

What's Happening with UNH Stock Today

UnitedHealth Group Inc (UNH) stock is higher by 4.39% while the S&P 500 has fallen -0.69% as of 2:04 PM on Thursday, May 14. UNH has gained $12.21 from the previous closing price of $277.99 on volume of 3,314,408 shares. Over the past year the S&P 500 is lower by -1.77% while UNH has gained 22.92%. UNH earned $14.28 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 20.32.

Click Here to get the full Stock Score Report on UnitedHealth Group Inc (UNH) Stock.

Share this article:

Related Companies

Upgrade to Premium and Analyze Stocks Like a Pro

50% Off All Subscriptions
InvestorsObserver Premium
InvestorsObserver Premium
InvestorsObserver Premium
Save up to 65% with annual

InvestorsObserver Premium

$ 20.75 $ 10.38 /month
$249 $124.50 billed annually

You May Also Like

Related Articles

Is it Time to Dump Synlogic Inc (SYBX) Stock After it Is Up 5.80% in a Week?

Is Rubius Therapeutics Inc (RUBY) a Stock to Watch This Week?

What is the Market's View on RedHill Biopharma Ltd (RDHL) Stock's Price and Volume Trends

Is it Time to Dump Vaxcyte Inc (PCVX) Stock After it Has Gained 10.68% in a Week?

Should You Buy Kaleido Biosciences Inc (KLDO) Stock After it Has Risen 21.73% in a Week?

Related Companies